Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples

BACKGROUND: Hepatitis C virus (HCV) antigen and antibody combination assays have been launched as a cost-effective alternative to nucleic acid testing (NAT) for reducing the antibody-negative window period (WP). Later, a HCV antigen chemiluminescence immunoassay (CLIA) became available. STUDY DESIGN...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transfusion
Main Authors: Laperche, Syria, Nubling, C. Micha, Stramer, Susan L., Brojer, Ewa, Grabarczyk, Piotr, Yoshizawa, Hiroshi, Kalibatas, Vytenis, El Elkyabi, Magdy, Moftah, Faten, Girault, Annie, van Drimmelen, Harry, Busch, Michael P., Lelie, Nico
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4744653/
https://ncbi.nlm.nih.gov/pubmed/26013970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.13179
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki